and receptor density/ distribution [10] as humans, in terms of the eCB system, further scale-up studies establishing a dose-response curve, the effect of chronic administrations and/or the use of other ligands and eCB modulators (FAAH inhibitors) will significantly contribute to our growing knowledge on this system’s role on anxiety.